-
-
-
-
-
-
-
Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older
-
-
-
-
-
-
-
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
-
-
-
-
-
-
-
U.S. CDC backs COVID boosters for children 5 to 11
-
-
-
-
-
-
-
BioNTech Announces Third Quarter 2021 Financial Results and Corporate Update
-
-
-
-
-
-
-
Pfizer And BioNTech to Provide U.S. Government an Additional 50 Million Pediatric Doses of COVID-19 Vaccine to Support Further Preparedness for Future Needs
-
-
-
-
-
-
-
U.S. FDA considering lowering recommended age for Pfizer/BioNTech COVID-19 boosters
-
-
-
-
-
-
-
Regulators could OK Pfizer boosters for older Americans this week
-
13,127 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All